Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Cash flows from operating activities:
Net income (loss)	$ 93	$ (2,713)
Adjustments to reconcile net income (loss) to net cash from operating activities:
Depreciation and amortization	425	500
Accretion of financing instruments	235	13
Impairment charge on investment in iBio, Inc.	139
Change in fair value of derivative instruments	133	(9)
Allowance for doubtful accounts	(13)	(3)
Non cash charge of professional fees incurred in connection with Convertible Note Payable - CD Financial, LLC		53
Loss on sale of property and equipment	6	1
Stock-based compensation		10
Decrease (increase) in:
Accounts receivable	(371)	(627)
Inventories	(1,140)	2,106
Prepaid expenses and other current assets	81	(641)
(Decrease) increase in:
Accounts payable	(598)	(352)
Accrued expenses and other current liabilities	(428)	891
Net cash used in operating activities	(1,438)	(771)
Cash flows from investing activities:
Purchase of property and equipment	(30)	(155)
Proceeds from sale of property and equipment	19	12
Net cash used in investing activities	(11)	(143)
Cash flows from financing activities:
Proceeds from issuance of notes payable		3,768
Repayments under capitalized lease obligations	(11)	(20)
Net cash provided by financing activities	1,359	334
Advances under revolving credit facility	34,714	2,679
Repayments of advances under revolving credit facility	(32,848)	(2)
Repayments under term note payables	(496)	(7,805)
Net decrease in cash	(90)	(580)
Cash at beginning of fiscal year	145	725
Cash at end of fiscal year	55	145
CD Financial LLC [Member]
Cash flows from financing activities:
Proceeds from issuance of notes payable		$ 1,714